查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942758

2026年全球药品和医疗设备组合市场报告

Drug Device Combination Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医药医疗设备组合产品的市场规模迅速扩张，预计将从2025年的1,442.2亿美元成长到2026年的1,614.8亿美元，复合年增长率达12.0%。过去几年的成长归因于多种因素，例如慢性病盛行率的上升、注射药物疗法的推广、生物製药研发的进步、自我给药装置的日益普及以及组合产品的监管核准增多。

预计未来几年，药物-医疗设备组合产品市场将快速成长，到2030年市场规模将达到2,493.3亿美元，复合年增长率（CAGR）为11.5%。预测期内的成长要素包括：个人化医疗的日益普及、对数位疗法的投资不断增加、家庭给药的扩展、对互联医疗设备需求的增长以及对精准药物标靶化的日益重视。预测期内的主要趋势包括：智慧给药装置的日益普及、对以患者为中心的组合产品的需求不断增长、数位监测在给药过程中的整合程度不断提高、标靶治疗给药系统的扩展以及对个性化治疗平台的日益重视。

慢性病发病率的上升预计将推动对药物-医疗设备组合产品的需求。慢性病通常指持续超过一年，且会限制日常活动或需要持续医疗管理，或两者兼具的疾病。例如心血管疾病和糖尿病。药物-医疗设备组合产品透过将特定的药物疗法与专门的给药系统结合，帮助管理这些长期疾病。这可以实现精准给药，提高患者依从性，并改善长期治疗效果。例如，根据美国疾病管制与预防中心2024年10月发布的报告，超过90%的65岁及以上成年人至少患有一种慢性病。因此，慢性病负担的加重正在促使药物-医疗设备组合解决方案的普及应用。

主要企业的製药和医疗设备公司正优先开发先进的给药平台，包括整合针头隔离和自动復溶功能的盒式自动注射器。这些系统由两个腔室组成，一个腔室装有冻干药物製剂，另一个腔室装有稀释剂，从而可以在给药前立即进行精确混合。例如，总部位于瑞士的药物输送设备公司SHL Medical于2025年6月推出了Reunite，这是一款基于该公司专有的针头隔离技术的三级双腔自动注射器，可实现冷冻干燥药物的自动復溶和给药。该设备的核心是一个双腔药盒，可在储存和配製过程中隔离针头，并透过简单的解锁-旋转-按压操作实现自动混合和注射。其他功能包括：无需手动操作的机械针头隔离机制、可自订的套管规格和长度以控制注射深度和持续时间，以及与以往需要复杂管瓶配製的冻干生物製药的兼容性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药品和医疗设备组合市场：吸引力评分和分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 智慧型药物传输装置的应用日益普及
    • 以患者为中心的组合产品的需求日益增长
    • 推进药物传输中数位监测的整合
    • 扩展标靶治疗输送系统
    • 日益关注个人化治疗平台

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 居家医疗环境
  • 门诊治疗中心
  • 专业治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球医药及医疗设备组合市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素及限制因素）
  • 全球药品医疗设备组合市场规模、对比及成长率分析
  • 全球药品和医疗设备组合市场表现：规模和成长，2020-2025年
  • 全球药品和医疗设备组合市场预测：规模和成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 自动注射器、微针贴片、电子药丸、智慧型吸入器、药物传输水凝胶、药物释放镜片及其他产品
  • 透过分销管道
  • 直接竞标、零售和其他通路
  • 透过使用
  • 整形外科疾病、呼吸系统疾病、糖尿病、肿瘤、心血管疾病及其他适应症
  • 最终用户
  • 诊所、医院、居家医疗机构、门诊护理中心和其他最终用户
  • 按类型细分：自动注射器
  • 预填充自动注射器，可重复使用的自动注射器
  • 按类型细分：微针贴片
  • 可溶性微针贴片，涂布微针贴片
  • 按类型细分：电子药丸
  • 口服型感测器，智慧胶囊
  • 按类型细分：智慧吸入器
  • 定量吸入器（MDI）、干粉吸入器（DPI）
  • 按类型细分：药物递送水凝胶
  • 注射用水凝胶，外用水凝胶
  • 按类型细分：药物洗脱镜片
  • 隐形眼镜，人工水晶体
  • 按类型细分：其他产品
  • 经皮贴片、植入式药物传递系统

第十章 区域与国家分析

  • 全球药品和医疗设备组合市场：按地区划分，实际值和预测值，2020-2025年、2025-2030年预测值、2035年预测值
  • 全球药品和医疗设备组合市场：按国家/地区划分，实际值和预测值，2020-2025 年、2025-2030 年预测值、2035 年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物-医疗设备组合市场：竞争格局及市场占有率（2024年）
  • 医药及医疗设备组合市场：公司估值矩阵
  • 药品和医疗设备组合市场：公司概况
    • The 3M Company
    • Abbott India Ltd.
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Medtronic PLC

第37章：其他领先和创新企业

  • Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Lepu Medical Technology（Beijing）Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药品-医疗设备组合市场：提供新机会的国家
  • 2030年药物-医疗设备组合市场：充满新机会的细分市场
  • 2030年药品和医疗设备组合市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MDDCE01_G26Q1

Drug-device combinations refer to therapeutic and diagnostic products that combine a medical device with a drug, facilitating localized drug administration, precise drug targeting, and personalized therapy. These combinations create a unified entity, physically and chemically, packaged together in a single package. Drug-device combinations play a crucial role in clinical development, enabling the delivery of drugs to specific locations in the body.

The primary types of drug-device combination products include auto-injectors, microneedle patches, digital pills, smart inhalers, drug delivery hydrogels, drug-eluting lenses, and other products. These products find applications in various medical fields such as orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, among others. The end users of drug-device combination products include clinics, hospitals, home care settings, ambulatory care centers, and others. These products are distributed through direct tenders, retail sales, and other distribution channels.

Tariffs are influencing the drug device combination market by increasing costs of imported polymers, sensors, electronic components, and precision molding equipment used in auto-injectors, smart inhalers, and digital pills. Healthcare manufacturers in North America and Europe are most affected due to reliance on global component sourcing, while Asia-Pacific faces pricing pressure on device exports. These tariffs are increasing production costs and lengthening commercialization timelines. However, they are also encouraging domestic device manufacturing, localized assembly, and innovation in cost-efficient combination product designs.

The drug device combination market research report is one of a series of new reports from The Business Research Company that provides drug device combination market statistics, including drug device combination industry global market size, regional shares, competitors with a drug device combination market share, detailed drug device combination market segments, market trends and opportunities, and any further data you may need to thrive in the drug device combination industry. This drug device combination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug device combination market size has grown rapidly in recent years. It will grow from $144.22 billion in 2025 to $161.48 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, expansion of injectable drug therapies, growth in biologics development, rising use of self-administration devices, increasing regulatory approvals for combination products.

The drug device combination market size is expected to see rapid growth in the next few years. It will grow to $249.33 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine, rising investments in digital therapeutics, expansion of home-based drug delivery, growing demand for connected medical devices, increasing focus on precision drug targeting. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising demand for patient-centric combination products, growing integration of digital monitoring in drug delivery, expansion of targeted therapy delivery systems, enhanced focus on personalized treatment platforms.

The rising incidence of chronic conditions is expected to propel demand for drug-device combination products. Chronic conditions are illnesses that typically last a year or more and can limit daily activities, require ongoing medical attention, or both, including conditions such as cardiovascular disease and diabetes. Drug-device combination products support the management of these long-term conditions by pairing specific pharmaceutical therapies with dedicated delivery systems, which enable accurate dosing, improve patient compliance, and enhance long-term treatment outcomes. For example, in October 2024, a report published by the Centers for Disease Control and Prevention stated that more than 90% of adults aged 65 years and older are living with at least one chronic condition. As a result, the growing burden of chronic diseases is contributing to increased adoption of drug-device combination solutions.

Leading players in the drug-device combination space are prioritizing the development of advanced delivery platforms, including dual-chamber, cartridge-based autoinjectors equipped with integrated needle-isolation and automated reconstitution capabilities. These systems are designed with two separate chambers, one holding a lyophilized drug formulation and the other containing a diluent, allowing controlled mixing immediately before administration. For instance, in June 2025, SHL Medical, a Switzerland-based drug delivery device company, introduced Reunite, a three-step, dual-chamber cartridge autoinjector built on the company's proprietary Needle Isolation Technology to enable automated reconstitution and administration of lyophilized therapies. The device is structured around a dual-chamber cartridge that keeps the needle isolated during storage and preparation, operates through a simple unlock-twist-push workflow to automate mixing and injection, and offers features such as mechanical needle isolation to avoid manual handling, customizable cannula gauge and length to control injection depth and duration, and compatibility with lyophilized biologics that traditionally require complex vial-based preparation.

In May 2023, Closed Loop Medicine Ltd, a UK-based TechBio company focused on developing combination prescription drug and software therapy products, formed a partnership with Pharmanovia. Through this collaboration, Closed Loop Medicine Ltd. aims to advance precision medicine strategies that utilize genetic and molecular profiling to determine the most effective drug combinations for individual patients. Pharmanovia is a UK-based pharmaceutical company.

Major companies operating in the drug device combination market are The 3M Company, Abbott India Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Medtronic PLC, Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Lepu Medical Technology (Beijing) Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc., Alcon Inc., W. L. Gore & Associates Inc., Cook Medical LLC, Pinnacle Biologics Inc.

North America was the largest region in the drug-device combination market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug device combination market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug device combination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-device combination market consists of sales of catheter and advanced wound care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Device Combination Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug device combination market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug device combination ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug device combination market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Auto-Injector; Microneedle Patch; Digital Pill; Smart Inhaler; Drug Delivery Hydrogels; Drug-Eluting Lens; Other Products
  • 2) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
  • 3) By Application: Orthopedic Diseases; Respiratory Diseases; Diabetes; Oncology; Cardiovascular Diseases; Other Applications
  • 4) By End User: Clinics; Hospitals; Home Care Settings; Ambulatory Care Centers; Other End Users
  • Subsegments:
  • 1) By Auto-Injector: Pre-Filled Auto-Injectors; Reusable Auto-Injectors
  • 2) By Microneedle Patch: Dissolving Microneedle Patches; Coated Microneedle Patches
  • 3) By Digital Pill: Ingestible Sensors; Smart Capsules
  • 4) By Smart Inhaler: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs)
  • 5) By Drug Delivery Hydrogels: Injectable Hydrogels; Topical Hydrogels
  • 6) By Drug-Eluting Lens: Contact Lenses; Intraocular Lenses
  • 7) By Other Products: Transdermal Patches; Implantable Drug Delivery Systems
  • Companies Mentioned: The 3M Company; Abbott India Ltd.; Biotronik SE & Co. KG; Boston Scientific Corporation; Medtronic PLC; Ypsomed Holding AG; Micron Biomedical Inc.; MetP Pharma AG; Sonceboz SA; Lepu Medical Technology (Beijing) Co. Ltd.; Eitan Medical Ltd.; Vaxess Technologies Inc.; Subcuject Aps; Allergan PLC; Terumo Corporation; Stryker Corporation; Becton Dickinson and Company; Zimmer Biomet Holdings Inc.; MediPrint Ophthalmics; Arrow International Inc.; Alcon Inc.; W. L. Gore & Associates Inc.; Cook Medical LLC; Pinnacle Biologics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Device Combination Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Device Combination Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Device Combination Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Device Combination Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart Drug Delivery Devices
    • 4.2.2 Rising Demand For Patient-Centric Combination Products
    • 4.2.3 Growing Integration Of Digital Monitoring In Drug Delivery
    • 4.2.4 Expansion Of Targeted Therapy Delivery Systems
    • 4.2.5 Enhanced Focus On Personalized Treatment Platforms

5. Drug Device Combination Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Home Care Settings
  • 5.4 Ambulatory Care Centers
  • 5.5 Specialty Treatment Centers

6. Drug Device Combination Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Device Combination Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Device Combination PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Device Combination Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Device Combination Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Device Combination Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Device Combination Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Device Combination Market Segmentation

  • 9.1. Global Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens, Other Products
  • 9.2. Global Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Tender, Retail Sales, Other Distribution Channels
  • 9.3. Global Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, Other Applications
  • 9.4. Global Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers, Other End Users
  • 9.5. Global Drug Device Combination Market, Sub-Segmentation Of Auto-Injector, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pre-Filled Auto-Injectors, Reusable Auto-Injectors
  • 9.6. Global Drug Device Combination Market, Sub-Segmentation Of Microneedle Patch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dissolving Microneedle Patches, Coated Microneedle Patches
  • 9.7. Global Drug Device Combination Market, Sub-Segmentation Of Digital Pill, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ingestible Sensors, Smart Capsules
  • 9.8. Global Drug Device Combination Market, Sub-Segmentation Of Smart Inhaler, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)
  • 9.9. Global Drug Device Combination Market, Sub-Segmentation Of Drug Delivery Hydrogels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Injectable Hydrogels, Topical Hydrogels
  • 9.10. Global Drug Device Combination Market, Sub-Segmentation Of Drug-Eluting Lens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Contact Lenses, Intraocular Lenses
  • 9.11. Global Drug Device Combination Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transdermal Patches, Implantable Drug Delivery Systems

10. Drug Device Combination Market Regional And Country Analysis

  • 10.1. Global Drug Device Combination Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Device Combination Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Device Combination Market

  • 11.1. Asia-Pacific Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Device Combination Market

  • 12.1. China Drug Device Combination Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Device Combination Market

  • 13.1. India Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Device Combination Market

  • 14.1. Japan Drug Device Combination Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Device Combination Market

  • 15.1. Australia Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Device Combination Market

  • 16.1. Indonesia Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Device Combination Market

  • 17.1. South Korea Drug Device Combination Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Device Combination Market

  • 18.1. Taiwan Drug Device Combination Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Device Combination Market

  • 19.1. South East Asia Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Device Combination Market

  • 20.1. Western Europe Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Device Combination Market

  • 21.1. UK Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Device Combination Market

  • 22.1. Germany Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Device Combination Market

  • 23.1. France Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Device Combination Market

  • 24.1. Italy Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Device Combination Market

  • 25.1. Spain Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Device Combination Market

  • 26.1. Eastern Europe Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Device Combination Market

  • 27.1. Russia Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Device Combination Market

  • 28.1. North America Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Device Combination Market

  • 29.1. USA Drug Device Combination Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Device Combination Market

  • 30.1. Canada Drug Device Combination Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Device Combination Market

  • 31.1. South America Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Device Combination Market

  • 32.1. Brazil Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Device Combination Market

  • 33.1. Middle East Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Device Combination Market

  • 34.1. Africa Drug Device Combination Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Device Combination Market, Segmentation By Product, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Device Combination Market Regulatory and Investment Landscape

36. Drug Device Combination Market Competitive Landscape And Company Profiles

  • 36.1. Drug Device Combination Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Device Combination Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Device Combination Market Company Profiles
    • 36.3.1. The 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott India Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

37. Drug Device Combination Market Other Major And Innovative Companies

  • Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Lepu Medical Technology (Beijing) Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc.

38. Global Drug Device Combination Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Device Combination Market

40. Drug Device Combination Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Device Combination Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Device Combination Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Device Combination Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer